Molecular detection of thyroglobulin mRNA transcripts in peripheral blood of patients with thyroid disease by RT-PCR

作者:

DOI: 10.1054/BJOC.1999.1209

关键词:

摘要: The sensitive detection of circulating tumour cells in patients with differentiated thyroid cancer may precede the relapse by other diagnostic studies – such as serum thyroglobulin and thus have important therapeutic prognostic implications. We performed reverse transcription-polymerase chain reaction (RT-PCR) on blood samples from diagnosed disease using two different RT-PCR sensitivities. Additionally, tissue specificity TG mRNA-expression was determined RNA extracts 27 human tissues. lower limit 50–100 mRNA producing cells/ml a ‘normal’ sensitivity 10–20 ‘high’ sensitivity. With normal detected 9/13 metastasis, 63/137 history no 21/85 non-malignant 9/50 controls. high 11/13 111/137 61/85 41/50 Interestingly, transcripts are specific for detectable peripheral controls disease, which correlates diagnosis metastasized cancer. However, sensitivity, expression found not to be correlated patients. As consequence, date cannot recommended marker superior serum-level. © 2000 Cancer Research Campaign

参考文章(26)
L G Gomella, J G Moreno, M Monne, C M Croce, R Fischer, P Vihko, S G Mulholland, Detection of hematogenous micrometastasis in patients with prostate cancer Cancer Research. ,vol. 52, pp. 6110- 6112 ,(1992)
W.J. Simpson, S.E. McKinney, J.S. Carruthers, M.K. Gospodarowicz, S.B. Sutcliffe, T. Panzarella, Papillary and follicular thyroid cancer: Prognostic factors in 1,578 patients The American Journal of Medicine. ,vol. 83, pp. 479- 488 ,(1987) , 10.1016/0002-9343(87)90758-3
Y H Datta, P T Adams, W R Drobyski, S P Ethier, V H Terry, M S Roth, Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction Journal of Clinical Oncology. ,vol. 12, pp. 475- 482 ,(1994) , 10.1200/JCO.1994.12.3.475
Ronald A Ghossein, Howard I Scher, William L Gerald, WK Kelly, Tracy Curley, Alison Amsterdam, Zuo-Feng Zhang, Juan Rosai, Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications. Journal of Clinical Oncology. ,vol. 13, pp. 1195- 1200 ,(1995) , 10.1200/JCO.1995.13.5.1195
G Tallini, R A Ghossein, J Emanuel, J Gill, B Kinder, A B Dimich, J Costa, R Robbins, G N Burrow, J Rosai, Detection of thyroglobulin, thyroid peroxidase, and RET/PTC1 mRNA transcripts in the peripheral blood of patients with thyroid disease. Journal of Clinical Oncology. ,vol. 16, pp. 1158- 1166 ,(1998) , 10.1200/JCO.1998.16.3.1158
S. L. Parker, T. Tong, S. Bolden, P. A. Wingo, Cancer statistics, 1997 CA: A Cancer Journal for Clinicians. ,vol. 47, pp. 5- 27 ,(1997) , 10.3322/CANJCLIN.47.1.5
A J Herle, R P Uller, Elevated serum thyroglobulin. A marker of metastases in differentiated thyroid carcinomas. Journal of Clinical Investigation. ,vol. 56, pp. 272- 277 ,(1975) , 10.1172/JCI108090
Matthew D. Ringel, Paul W. Ladenson, Michael A. Levine, Molecular diagnosis of residual and recurrent thyroid cancer by amplification of thyroglobulin messenger ribonucleic acid in peripheral blood. The Journal of Clinical Endocrinology and Metabolism. ,vol. 83, pp. 4435- 4442 ,(1998) , 10.1210/JCEM.83.12.5346
Beth Ann Ditkoff, Michael R. Marvin, Shrishailam Yemul, Y.J. Shi, John Chabot, Carl Feind, Paul Lo Gerfo, Detection of circulating thyroid cells in peripheral blood Surgery. ,vol. 120, pp. 959- 965 ,(1996) , 10.1016/S0039-6060(96)80041-9
Laura E. Sanders, Blake Cady, Differentiated thyroid cancer: reexamination of risk groups and outcome of treatment. Archives of Surgery. ,vol. 133, pp. 419- 425 ,(1998) , 10.1001/ARCHSURG.133.4.419